Advertisement

Clinical Rheumatology

, Volume 37, Issue 8, pp 2179–2186 | Cite as

A novel biomarker in patients with knee osteoarthritis: adropin

  • Gulsah Gundogdu
  • Koksal Gundogdu
Original Article

Abstract

Adropin is newly discovered peptide hormone. Osteoarthritis (OA) is a kind of joint disease characterized by progressive joint cartilage loss and joint pain. The present study was carried out to investigate adropin and tumor necrosis factor alpha (TNF-α) levels and the relationship between adropin in patients with knee OA classified by Kellgren-Lawrence (KL). A total of 60 knee OA patients and 30 healthy controls were included in this study. KL grading was carried out using the radiographic findings. Demographic characteristics and laboratory parameters were recorded. Adropin and TNF-α levels were determined by using enzyme-linked immunosorbent assay (ELISA). Adropin level was lower in the knee OA patients compared with the healthy controls (p < 0.001), whereas TNF-α level was higher (p < 0.001). Adropin level was negatively correlated with TNF-α level, blood white blood cell (WBC) count, and neutrophil-lymphocyte ratio (NLR). However, there was a significant decrease in adropin level and an increase in TNF-α level parallel to the increase in the KL grade. In addition, serum adropin level was found to be significantly lower in KL grade 1 groups compared with healthy controls (p < 0.01). There was a decrease in adropin level parallel to the increase in the body mass index (BMI), and there was a statistically significant decrease in adropin level in knee OA patients higher than BMI > 30 (p < 0.01). Mean NLR of KL grade 4 was significantly increased compared with other grades (p < 0.05). The consequence of the present study suggested that serum adropin level could be used as a new biomarker indicating the early grade of knee OA.

Keywords

Adropin Knee osteoarthritis Tumor necrosis factor alpha 

Notes

Compliance with ethical standards

Disclosures

None.

References

  1. 1.
    Nawaz MS, Amer N, Asim HM (2017) Grade 1-2 osteoarthritis of knee joint; outcome of combination of grade 1-2 knee joint mobilization with quadriceps isometrics in patients. Professional Med J 24(7):986–991CrossRefGoogle Scholar
  2. 2.
    Hurwitz EL, Carragee EJ, van der Velde G, Carroll LJ, Nordin M, Guzman J, Peloso PM, Holm LW, Cote P, Hogg-Johnson S, Cassidy JD, Haldeman S (2009) Treatment of neck pain: noninvasive interventions: results of the Bone and Joint Decade 2000-2010 Task Force on Neck Pain and Its Associated Disorders. J Manipulative Physiol Ther 32(2 Suppl):141–175Google Scholar
  3. 3.
    Uysal FG, Basaran S (2009) Knee Osteoarthritis. Turk Fiz Tip Rehab D 55:1–7Google Scholar
  4. 4.
    Sokolove J, Lepus CM (2013) Role of inflammation in the pathogenesis of osteoarthritis: latest findings and interpretations. Ther Adv Musculoskelet Dis 5(2):77–94CrossRefPubMedPubMedCentralGoogle Scholar
  5. 5.
    Maldonado M, Nam J (2013) The role of changes in extracellular matrix of cartilage in the presence of inflammation on the pathology of osteoarthritis. Biomed Res Int 2013:284873CrossRefPubMedPubMedCentralGoogle Scholar
  6. 6.
    Amin S, LaValley MP, Guermazi A, Grigoryan M, Hunter DJ, Clancy M, Niu JB, Gale DR, Felson DT (2005) The relationship between cartilage loss on magnetic resonance imaging and radiographic progression in men and women with knee osteoarthritis. Arthritis Rheum 52(10):3152–3159CrossRefPubMedGoogle Scholar
  7. 7.
    Kellgren JH, Lawrence JS (1957) Radiological assessment of osteoarthritis. Ann Rheum Dis 16(4):494–502CrossRefPubMedPubMedCentralGoogle Scholar
  8. 8.
    Katz JD, Agrawal S, Velasquez M (2010) Getting to the heart of the matter: osteoarthritis takes its place as part of the metabolic syndrome. Curr Opin Rheumatol 22(5):512–519CrossRefPubMedGoogle Scholar
  9. 9.
    Bondeson J, Blom AB, Wainwright S, Hughes C, Caterson B, van den Berg WB (2010) The role of synovial macrophages and macrophage-produced mediators in driving inflammatory and destructive responses in osteoarthritis. Arthritis Rheum 62(3):647–657CrossRefPubMedGoogle Scholar
  10. 10.
    Franke S, Sommer M, Ruster C, Bondeva T, Marticke J, Hofmann G, Hein G, Wolf G (2009) Advanced glycation end products induce cell cycle arrest and proinflammatory changes in osteoarthritic fibroblast-like synovial cells. Arthritis Res Ther 11(5):1–19CrossRefGoogle Scholar
  11. 11.
    Kumar KG, Trevaskis JL, Lam DD, Sutton GM, Koza RA, Chouljenko VN, Kousoulas KG, Rogers PM, Kesterson RA, Thearle M, Ferrante AW, Mynatt RL, Burris TP, Dong JZ, Halem HA, Culler MD, Heisler LK, Stephens JM, Butler AA (2008) Identification of Adropin as a Secreted Factor Linking Dietary Macronutrient Intake with Energy Homeostasis and Lipid Metabolism. Cell Metab 8(6):468-481CrossRefPubMedPubMedCentralGoogle Scholar
  12. 12.
    Lian WL, Gu XS, Qin YW, Zheng X (2011) Elevated Plasma Levels of Adropin in Heart Failure Patients. Internal Med 50(15):1523–1527CrossRefGoogle Scholar
  13. 13.
    Butler AA, Tam CS, Stanhope KL, Wolfe BM, Ali MR, O’Keeffe M, St-Onge MP, Ravussin E, Havel PJ (2012) Low Circulating Adropin Concentrations with Obesity and Aging Correlate with Risk Factors for Metabolic Disease and Increase after Gastric Bypass Surgery in Humans. J Clin Endocr Metab 97(10):3783–3791CrossRefPubMedGoogle Scholar
  14. 14.
    Chen M, Ouyang F, Zhou SH (2015) Adropin as a novel energy factor likely has the ability to regulate blood pressure. Med Hypotheses 85(2):234CrossRefPubMedGoogle Scholar
  15. 15.
    Celik E, Yilmaz E, Celik O, Ulas M, Turkcuoglu I, Karaer A, Simsek Y, Minareci Y, Aydin S (2013) Maternal and fetal adropin levels in gestational diabetes mellitus. J Perinat Med 41(4):375–380CrossRefPubMedGoogle Scholar
  16. 16.
    Gu XS, Li H, Zhu XY, Gu HB, Chen JC, Wang LC, Harding P, Xu WT (2015) Inverse correlation between plasma adropin and ET-1 levels in essential hypertension: a cross-sectional study. Medicine 94(40):1–5CrossRefGoogle Scholar
  17. 17.
    Kumar KG, Zhang JY, Gao S, Rossi J, McGuinness OP, Halem HH, Culler MD, Mynatt RL, Butler AA (2012) Adropin Deficiency Is Associated With Increased Adiposity and Insulin Resistance. Obesity 20(7):1394–1402Google Scholar
  18. 18.
    Li ZM, Li M (2017) Improvement in orthopedic outcome score and reduction in IL-1β, CXCL13, and TNF-α in synovial fluid of osteoarthritis patients following arthroscopic knee surgery. Genet Mol Res 16(3):1–9CrossRefGoogle Scholar
  19. 19.
    Sasek C (2015) An update on primary care management of knee osteoarthritis. Jaapa-J Am Acad Phys 28(1):37-44Google Scholar
  20. 20.
    Johnson VL, Hunter DJ (2014) The epidemiology of osteoarthritis. Best Pract Res Clin Rheumatol 28:5–15CrossRefPubMedGoogle Scholar
  21. 21.
    Grazio S, Balen D (2009) Obesity: risk factor and predictor of osteoarthritis. Lijec Vjesn 131(1–2):22–26PubMedGoogle Scholar
  22. 22.
    Lementowski PW, Zelicof SB (2008) Obesity and osteoarthritis. Am J Orthop 37:148–151PubMedGoogle Scholar
  23. 23.
    Engstrom G, de Verdier MG, Rollof J, Nilsson PM, Lohmander LS (2009) C-reactive protein, metabolic syndrome and incidence of severe hip and knee osteoarthritis. A population-based cohort study. Osteoarthr Cartilage 17(2):168–173 Google Scholar
  24. 24.
    Gandhi R, Razak F, Tso P, Davey JR, Mahomed NN (2010) Asian ethnicity and the prevalence of metabolic syndrome in the osteoarthritic total knee arthroplasty population. J Arthroplast 25(3):416–419CrossRefGoogle Scholar
  25. 25.
    Han CD, Yang IH, Lee WS, Park YJ, Park KK (2013) Correlation between metabolic syndrome and knee osteoarthritis: data from the Korean National Health and Nutrition Examination Survey (KNHANES). BMC Public Health 13(603):1–8Google Scholar
  26. 26.
    Hussain SM, Wang YY, Cicuttini FM, Simpson JA, Giles GG, Graves S, Wluka AE (2014) Incidence of total knee and hip replacement for osteoarthritis in relation to the metabolic syndrome and its components: A prospective cohort study. Semin Arthritis Rheu 43(4):429–436CrossRefGoogle Scholar
  27. 27.
    Kurz B, Lemke AK, Fay J, Pufe T, Grodzinsky AJ, Schünke M (2005) Pathomechanisms of cartilage destruction by mechanical injury. Ann Anat 187:473–485CrossRefPubMedGoogle Scholar
  28. 28.
    Vasilic-Brasnjevic S, Marinkovic J, Vlajinac H, Vasiljevic N, Jakovljevic B, Nikic M, Maksimovic M (2016) Association of body mass index and waist circumference with severity of knee osteoarthritis. Acta Reumatol Port 41:226–231PubMedGoogle Scholar
  29. 29.
    Sayin O, Tokgoz Y, Arslan N (2014) Investigation of adropin and leptin levels in pediatric obesity-related nonalcoholic fatty liver disease. J Pediatr Endocr Met 27(5-6):479–484Google Scholar
  30. 30.
    Topuz M, Celik A, Aslantas T, Demir AK, Aydin S, Aydin S (2013) Plasma Adropin Levels Predict Endothelial Dysfunction Like Flow-Mediated Dilatation in Patients With Type 2 Diabetes Mellitus. J Invest Med 61(8):1161–1164CrossRefGoogle Scholar
  31. 31.
    Orlowsky EW, Kraus VB (2015) The role of innate immunity in osteoarthritis: when our first line of defense goes on the offensive. J Rheumatol 42(3):363–371CrossRefPubMedPubMedCentralGoogle Scholar
  32. 32.
    He R, Yang L, Guo L (2011) Painful locking of the knee due to bucket handle tear of mediopatellar plica. Chin J Traumatol 14:117–119PubMedGoogle Scholar
  33. 33.
    Nelson FR (2014) A background for the management of osteoarthritic knee pain. Pain Manag 4(6):427–436CrossRefPubMedGoogle Scholar
  34. 34.
    Hotamisligil GS, Shargill NS, Spiegelman BM (1993) Adipose Expression of Tumor-Necrosis-Factor-Alpha - Direct Role in Obesity-Linked Insulin Resistance. Science 259(5091):87–91CrossRefPubMedGoogle Scholar
  35. 35.
    Spiegelman BM, Flier JS (2001) Obesity and the regulation of energy balance. Cell 104(4):531–543CrossRefPubMedGoogle Scholar
  36. 36.
    Chen XP, Xun KL, Chen LD, Wang YT (2009) TNF-alpha, a potent lipid metabolism regulator. Cell Biochem Funct 27(7):407–416CrossRefPubMedGoogle Scholar
  37. 37.
    Gupta-Ganguli M, Cox K, Means B, Gerling I, Solomon SS (2011) Does therapy with anti-TNF-alpha improve glucose tolerance and control in patients with type 2 diabetes? Diabetes Care 34(7):e121CrossRefPubMedPubMedCentralGoogle Scholar
  38. 38.
    Finck BN, Johnson RW (2000) Tumor necrosis factor-alpha regulates secretion of the adipocyte-derived cytokine, leptin. Microsc Res Techniq 50(3):209–215CrossRefGoogle Scholar
  39. 39.
    Rask-Madsen C, Dominguez H, Ihlemann N, Hermann T, Kober L, Torp-Pedersen C (2003) Tumor necrosis factor-alpha inhibits insulin’s stimulating effect on glucose uptake and endothelium-dependent vasodilation in humans. Circulation 108(15):1815–1821CrossRefPubMedGoogle Scholar
  40. 40.
    Plomgaard P, Bouzakri K, Krogh-Madsen R, Mittendorfer B, Zierath JR, Pedersen BK (2005) Tumor necrosis factor-alpha induces skeletal muscle insulin resistance in healthy human subjects via inhibition of Akt substrate 160 phosphorylation. Diabetes 54:2939–2945CrossRefPubMedGoogle Scholar
  41. 41.
    Shao N, Cai Q (2015) High pretreatment neutrophil-lymphocyte ratio predicts recurrence and poor prognosis for combined small cell lung cancer. Clin Transl Oncol 17(10):772–778CrossRefPubMedGoogle Scholar
  42. 42.
    Buyukkaya E, Karakas MF, Karakas E, Akcay AB, Tanboga IH, Kurt M, Sen N (2014) Correlation of neutrophil to lymphocyte ratio with the presence and severity of metabolic syndrome. Clin Appl Thromb Hemost 20(2):159–163CrossRefPubMedGoogle Scholar
  43. 43.
    Demirci S, Demirci S, Kutluhan S, Koyuncuoğlu HR, Yürekli VA (2016) The clinical significance of the neutrophil-to-lymphocyte ratio in multiple sclerosis. Int J Neurosci 126(8):700–706PubMedGoogle Scholar
  44. 44.
    Suliman MARM, Juma AAB, Almadhani AAA, Pathare AV, Alkindi SSA, Werner FU (2010) Predictive Value of Neutrophil to Lymphocyte Ratio in Outcomes of Patients with Acute Coronary Syndrome. Arch Med Res 41(8):618–622Google Scholar
  45. 45.
    Tasoglu O, Boluk H, Onat SS, Tasoglu I, Ozgirgin N (2016) Is blood neutrophil-lymphocyte ratio an independent predictor of knee osteoarthritis severity? Clin Rheumatol 35(6):1579–1583CrossRefPubMedGoogle Scholar

Copyright information

© International League of Associations for Rheumatology (ILAR) 2018

Authors and Affiliations

  1. 1.Department of Physiology, Faculty of MedicineAtatürk UniversityErzurumTurkey
  2. 2.Department of Orthopaedics and TraumatologyErzurum Regional Training and Research HospitalErzurumTurkey

Personalised recommendations